TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Revenue

In the year 2025, TScan Therapeutics had annual revenue of $10.33M with 266.65% growth. TScan Therapeutics had revenue of $2.57M in the quarter ending December 31, 2025, with 286.02% growth.

• Revenue (ttm): $10.33M
• Revenue Growth: +266.65%
• P/S Ratio: 5.45
• Revenue / Employee: $72,711
• Employees: 142
• Market Cap: 56.25M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.33M	7.51M	266.65%
Dec 31, 2024	2.82M	-18.23M	-86.62%
Dec 31, 2023	21.05M	7.51M	55.52%
Dec 31, 2022	13.54M	3.39M	33.47%
Dec 31, 2021	10.14M	9.06M	834.65%
Dec 31, 2020	1.09M	-	-
Dec 31, 2019	-	-	-